Pertussis: Clinical Trials

3 trials for Pertussis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Unknown 3
Phase 31Unknown 1

Follow Pertussis: new trials by email Literature Review of Pertussis trials Research Report on Pertussis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age
LR20062, DTaP-HepB-IPV-Hib vaccine - Diphtheria, Tetanus
Phase 2UnknownLG Chem3362024-10-022024-10-01
Safety and Immunogenicity of 2 Doses Versus 1 Dose of Acellular Pertussis Vaccines Containing Genetically-detoxified Pertussis Toxin in Young Adults Previously Primed With Acellular Pertussis Vaccines
Pertagen®, Revaxis® - Pertussis, Vaccine-Preventable Diseases
Phase 2 / Phase 3UnknownUniversity Hospital, Geneva1002022-02-072022-01-18
Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy Infants
DTwP-HepB-Sabin IPV-Hib, Pentavalent vaccine and Salk IPV - Diphtheria, Tetanus
Phase 2UnknownLG Chem3362019-11-012019-09-06

Narrower conditions

Whooping Cough (3)  ·  Diphtheria (2)  ·  Haemophilus Infections (2)  ·  Hepatitis B (2)  ·  Poliomyelitis (2)  ·  Tetanus (2)  ·  Vaccine-Preventable Diseases (1)

Broader conditions

Bacterial Infections (3)  ·  Bacterial Infections and Mycoses (3)  ·  Bordetella Infections (3)  ·  Gram-Negative Bacterial Infections (3)  ·  Infections (3)  ·  Respiratory Tract Diseases (3)  ·  Respiratory Tract Infections (3)  ·  Actinomycetales Infections (2)  ·  Blood-Borne Infections (2)  ·  Central Nervous System Diseases (2)  ·  Central Nervous System Infections (2)  ·  Clostridium Infections (2)  ·  Communicable Diseases (2)  ·  Corynebacterium Infections (2)  ·  DNA Virus Infections (2)

Interventions

FHD (1)  ·  Vaccines, Combined (1)

Sponsors

LG Chem (2)  ·  University Hospital, Geneva (1)

Countries

Switzerland (1)